Biotech

All Articles

Novo inks $600M NanoVation bargain to examine genetic medicines ex-liver

.Novo Nordisk is continuing its own push right into genetic medicines, accepting to compensate NanoV...

Innovent web links cytokine to colon cancer cells actions

.Innovent Biologics has produced the case that its gate inhibitor-cytokine combination protein posse...

Merck, Daiichi ADC strikes objective in period 3 lung cancer cells study

.A phase 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina strengthens artificial intelligence center with collab to choose cancer cells aim ats

.5 months after Rakovina Rehabs pivoted towards expert system, the cancer-focused biotech has actual...

Ascendis' dwarfism drug favorites in stage 3, threatens BioMarin

.Ascendis Pharma has emerged as a potential risk to BioMarin's Voxzogo, reporting period 3 developme...

Despite ph. 3 miss, Alkeus views path in advance for eye health condition asset

.Though Alkeus Pharmaceuticals' oral eye disease possession neglected to significantly decrease geog...

Kairos goes public along with $6M IPO to cash trials of cancer cells medicine

.With a trio of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to miss a sm...

Vaccine and Keytruda combo helpful in squamous tissue cancer

.Immune system checkpoint inhibitors are the superheroes of cancer treatment. Drugs like Bristol Mye...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shootings...

Regeneron's Opdualag opponent reveals 57% response price

.Regeneron is actually back along with lasting follow-up for its own LAG-3 inhibitor and also PD-1 p...